Therapeutic Effect of IF_(α-2b)Plus Compound Glycyrrhizin on Chronic Hepatitis C
Weiwei Sun
Abstract
Weiwei Sun
Abstract
OBJECTIVE:To observe the therapeutic effect of IF α-2b plus compound glycyrrhizin on chronic hepatitis C. METHODS:56cases of chronic hepatitis C were divided into trial group(30cases)and control group(26cases).Trial group received IF α-2b +compound glycyrrhizin and control group received IF α-2b alone.The therapeutic course was24weeks in both groups.RESULTS:There was significant difference in recoversion rate of ALT between two groups either at the end of therˉapeutic course or24weeks after treatment(P0.05).The negative conversion rate of HCV-RNA in trial group was significa_ ntly different from that in control group(P0.05).CONCLUSION:IF in combination with compound glycyrrhizin could improve the therapeutic effect on chronic hepatitis C.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To observe the therapeutic effect of IF α-2b plus compound glycyrrhizin on chronic hepatitis C. METHODS:56cases of chronic hepatitis C were divided into trial group(30cases)and control group(26cases).Trial group received IF α-2b +compound glycyrrhizin and control group received IF α-2b alone.The therapeutic course was24weeks in both groups.RESULTS:There was significant difference in recoversion rate of ALT between two groups either at the end of therˉapeutic course or24weeks after treatment(P0.05).The negative conversion rate of HCV-RNA in trial group was significa_ ntly different from that in control group(P0.05).CONCLUSION:IF in combination with compound glycyrrhizin could improve the therapeutic effect on chronic hepatitis C.
Key concepts: Glycyrrhizin, Therapeutic effect, Chronic hepatitis, Medicine, Significant difference, Negative control, Internal medicine, Gastroenterology